Pharming Group NV is a specialty pharmaceutical company focused on developing innovative therapies for rare diseases and unmet medical needs, with a strong presence in the United States, Europe, and beyond. Headquartered in Leiden, the Netherlands, Pharming leverages its cutting-edge recombinant DNA technology to produce safe and effective treatments, positioning itself at the forefront of the biopharmaceutical industry. With a commitment to addressing critical health challenges, the company is dedicated to improving patient outcomes and expanding access to life-saving therapies globally.